Kassie Harrold

Insider Reports History

Entity
Individual
Location
C/O Mallinckrodt Pharmaceuticals, 675 Mcdonnell Blvd., Hazelwood, MO
Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kassie Harrold:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mallinckrodt plc EVP & Chief Compliance Officer Restricted Stock Units 5.13K Feb 2, 2024 Direct
Mallinckrodt plc EVP & Chief Compliance Officer Ordinary Shares 0 $37.50 Nov 14, 2023 Direct

Insider Reports Filed by Kassie Harrold

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NONE Mallinckrodt plc Feb 2, 2024 1 $0 4 Feb 6, 2024 EVP & Chief Compliance Officer
MNKTQ Mallinckrodt plc Nov 14, 2023 1 $0 4 Nov 16, 2023 EVP & Chief Compliance Officer
MNK Mallinckrodt plc Aug 17, 2023 1 -$3.84K 4 Aug 18, 2023 Chief Compliance Officer
MNK Mallinckrodt plc Jun 30, 2023 1 $0 4 Jul 5, 2023 Chief Compliance Officer
MNK Mallinckrodt plc Apr 3, 2023 1 $0 4 Apr 5, 2023 Chief Compliance Officer
MNK Mallinckrodt plc Dec 14, 2022 1 $0 4 Dec 22, 2022 Chief Compliance Officer
MNKPF Mallinckrodt plc Jun 16, 2022 5 $0 4 Jun 21, 2022 Chief Compliance Officer